Cargando…

ODP319 IGF-1 and BMI are Associated in Obese Patients with Acromegaly

Regulation of the growth hormone (GH) axis is complex and influenced by factors including age and nutritional status. Studies of individuals across the weight spectrum demonstrate an inverted U-shaped correlation between BMI and total IGF-1 levels; in both individuals with anorexia nervosa-range BMI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khiyami, Anamil, Fazeli, Pouneh, Mahmud, Hussain, Gardner, Paul, Zenonos, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625435/ http://dx.doi.org/10.1210/jendso/bvac150.1028

Ejemplares similares

ODP369 Weight Trajectory as a Predictor of Cushing's Disease
por: Thavaraputta, Subhanudh, et al.
Publicado: (2022)

ODP314 Gynecomastia as the Initial Presentation of Acromegaly.
por: Lim, Frederick, et al.
Publicado: (2022)

ODP306 Diplopia as Presenting Manifestation of Acromegaly
por: Rjoob, Hani, et al.
Publicado: (2022)

ODP320 Immune Organs Enlarged in Acromegaly: Evaluation of Thymus Volume in Patients with Acromegaly
por: Nahit Sendur, Suleyman, et al.
Publicado: (2022)

MON-319 Impact of Tumor Characteristics and Preoperative IGF-1 Levels on Postoperative Hormonal Remission Following Endoscopic Transsphenoidal Surgery in Patients with Acromegaly: A Single-Surgeon Series
por: Cardinal, Tyler, et al.
Publicado: (2020)

ODP341 Pachydermia lesions identified on imaging in a cohort of acromegaly patients
por: Roque, Joao, et al.
Publicado: (2022)

ODP348 Regional disparities in functional impairment due to arthropathy in patients with acromegaly.
por: Ahmad, Syed, et al.
Publicado: (2022)

ODP353 Sustained Suppression of IGF1 with AZP-3813, a Bicyclic 16-Amino Acid Peptide Antagonist of the Human Growth Hormone Receptor and a Potential New Treatment for Acromegaly
por: Culler, Michael, et al.
Publicado: (2022)

MON-298 IGF-1 in the Early Post-operative Assessment of Acromegaly
por: Donegan, Diane, et al.
Publicado: (2020)

ODP327 Joint Pain Score is Higher in Acromegaly Patients Despite Pain Relief Therapy and Joint Surgeries.
por: Ahmad, Syed, et al.
Publicado: (2022)

Polycystic ovary syndrome preceding the diagnosis of acromegaly: a retrospective study in 97 reproductive-aged women
por: Khiyami, Anamil M., et al.
Publicado: (2023)

PMON61 Evaluation of elevated IGF-1 in patients without clinical evidence of acromegaly
por: Careless, Laura, et al.
Publicado: (2022)

SUN-273 A Rare Case of IgG4-Related Hypophysitis
por: Ravindra, Sindhura, et al.
Publicado: (2020)

LBMON175 Nadir Growth Hormone Concentrations In Patients With Acromegaly Relate To Disease Activity, Glucose Metabolism, BMI And Sex
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2022)

MON-327 Soluble Alpha Klotho and IGF-I Before Surgery as Prognostic Factors to Acromegaly Long-term Remission
por: de Oliveira Longo Schweizer, Junia Ribeiro, et al.
Publicado: (2020)

OR16-6 Cardiometabolic Abnormalities in Patients with Acromegaly with Elevated Plasma IGF-1 Concentrations but GH Concentrations <2ng/ml
por: Hannon, Anne Marie, et al.
Publicado: (2019)

SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation
por: Gundluru, Rajani, et al.
Publicado: (2020)

SAT-435 Optimization of Pharmacological Treatment of Acromegaly: Impact on IGF-1 Levels Comparing Isolated Octreotide LAR and Combined Pharmacological Therapy
por: Naves, Luciana, et al.
Publicado: (2019)

MON-306 Acromegaly Comorbidity Costs, Quality of Life, and Mortality: Lifetime Comparisons for Controlled Acromegaly, Uncontrolled Acromegaly, and the General US Population
por: Whittington, Melanie D, et al.
Publicado: (2020)

FRI319 Diagnostic And Management Challenges In A Patient With A Giant Pituitary Lactosomatotroph Adenoma
por: Peixe, Carolina Ribeiro, et al.
Publicado: (2023)

ODP339 Nonfunctioning Giant Adenomas
por: Oliveira, Miriam C, et al.
Publicado: (2022)

The Pharmacological Burden of Comorbidities in Acromegaly
por: Fleseriu, Maria, et al.
Publicado: (2021)

ODP296 An unusual presentation of Glucagonoma syndrome.
por: Zare, Ahmad, et al.
Publicado: (2022)

ODP364 Prolactinomas in men: management challenges
por: Baciu, Ionela, et al.
Publicado: (2022)

SAT-451 Acromegaly and Thyroid Cancer
por: Danilowicz, Karina, et al.
Publicado: (2019)

SAT-257 Coexisting Craniopharyngioma and Acromegaly
por: Yang, Almira, et al.
Publicado: (2020)

Pleurihormonal Pituitary Adenomas Presenting as Acromegaly
por: Schwehr, Megan, et al.
Publicado: (2021)

The Secret Behind Anemia in Patients With Acromegaly
por: Firlatan, Busra, et al.
Publicado: (2021)

THU025 Acromegaly And Central Hyperthyroidism
por: Akhtar, Ahmad, et al.
Publicado: (2023)

THU060 Time To First Remission, Medical Therapy And Survival In Acromegaly: UK Acromegaly Register (UKAR) Study
por: Deshmukh, Harshal, et al.
Publicado: (2023)

Use of Oral Concomitant Medications in Patients With Acromegaly
por: Petersenn, Stephan, et al.
Publicado: (2021)

FRI356 SIADH In Acromegaly And Cerebrovascular Accident
por: Simrampreet, Gill, et al.
Publicado: (2023)

MON-310 Factors Associated with Remission After Surgery for Acromegaly
por: Cunha, Clara, et al.
Publicado: (2020)

ODP304 Cyclic Cushing Disease: A Diagnostic Challenge
por: Zubiran, Rafael, et al.
Publicado: (2022)

MON-323 IGF-I Variability and Its Association with Demographic and Clinical Characteristics in Patients with Acromegaly Treated with Injectable Somatostatin Receptor Ligands (SRLS); Results from an International Prospective Phase III Study
por: Samson, Susan Leanne, et al.
Publicado: (2020)

ODP299 Cabergoline Administration Markedly Improves Cognitive Impairment Associated with Macroprolactinoma
por: Hoang, Thanh, et al.
Publicado: (2022)

ODP300 c-MET expression in MEN1-associated neuroendocrine tumors
por: Ghosh, Raisa, et al.
Publicado: (2022)

ODP576 A pilot randomized clinical trial of intranasal oxytocin to promote weight loss in children, adolescents, and adults with hypothalamic obesity
por: Bamba, Vaneeta, et al.
Publicado: (2022)

ODP349 Risk of Coronavirus Disease 2019 (COVID-19) in patients with Cushing's Disease (CD) is increased and independently associated with both obesity and disease activity
por: Mascarenhas Nakano, Bruna M, et al.
Publicado: (2022)

MON-302 The Prevalence of Acromegaly in the Sleep Apnoea Clinic
por: Lynch, Julie Marie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rargpegjt1q5qs24h009qoeipg